Liver disease

Hepatitis (57)
Liver disease (31)

Synopsis: Domenii: Health: Health generale: Illness: Gastrointestinal diseases: Liver diseases: Liver disease:

They then grew a pure culture of this single organism in the lab. An early guess is that this particular microbe may be linked to obesity and fatty liver disease

and one later showed rising levels of liver enzymes that suggested liver disease. Although the researchers did not purify the virus before injecting it into the horses, Pablo Murcia, a virologist from the University of Glasgow,

Upon autopsytheir fatty liver disease resembled that of an alcoholic. However the culprit was excess sugar

In addition to diabetes, the researchers also think that interfering with pyruvate transport may help patients with nonalcoholic fatty liver disease, a condition common in people with obesity y

Of all major organs, the liver has the highest capacity to regenerate that why many liver diseases,

#Immune cells in liver drive fatty liver disease, liver cancer Fatty liver disease--alongside fatty liver due to massive alcohol consumption--is caused mainly by excessive consumption of fat

This is referred to as nonalcoholic fatty liver disease (NAFLD. If NAFLD becomes chronic--e g. through the constant uptake of high lipids

This can lead to nonalcoholic steatohepatitis (NASH)--a liver disease with clear detectable pathologic alteratons of the tissue.

These liver diseases (NAFLD and NASH) along with chronic viral infections are the most common causes of liver cancer or hepatocellular carcinoma (HCC.

T cells involved in the development of fatty liver disease NASH and HCC The mechanisms that cause diseases such as fatty liver disease steatohepatitis and HCC are still not widely understood.

However immune cells particularly CD8+T cells and NK T cells seem to play an important role.

Our results provide completely new insights into the development of these serious liver diseases. Building on this knowledge we now want to develop new preventive

and develop fatty liver disease and abnormal blood lipid levels. All of these increase the risk of developing diabetes and cardiovascular disease.

and animals FGF21 levels are elevated in association with obesity insulin resistance and nonalcoholic fatty liver disease.

May 6th, 2015improving Clinical Care and Patient Quality of life in Advanced Liver disease, d-LIVER Workshop, Milan, 27 may 2015 May 6th, 201 0

#More clues to how drug reverses obesity diabetes fatty liver disease In addition to illuminating how the drug amlexanox reverses obesity diabetes

and fatty liver disease the findings suggest a new pathway for future treatments. The research was published Jan 12 in Nature Communications.

This combination results in multiple health risks including high blood sugar and fatty liver disease. For years to gain insight into this phenomenon researchers focused on the role of altered insulin action in the liver in the production of triglycerides.

but instead reduces fatty liver disease in patients with type 2 diabetes. These results provide new insights into the pathogenesis of nonalcoholic liver disease

and provides new approaches to treat fatty liver disease which is now the most common liver disease in the world said Shulman.

Shulman and his team plan to apply similar methodology to translate their findings to insulin-resistant patients with type 2 diabetes hyperlipidemia and fatty liver disease e

#'Crispr'science: Newer genome editing tool shows promise in engineering human stem cells In a recent online report on the work in Molecular Therapy the Johns Hopkins team says the findings could streamline

and speed efforts to modify and tailor human-induced pluripotent stem cells (ipscs) for use as treatments

SERPINA1 a gene that when mutated causes alpha1-antitrypsin deficiency an inherited disorder that may cause lung and liver disease;

We found that it significantly reduced inflammation in the fat tissues and improved kidney and liver disease.

"Our ultimate hope would be to use these findings to create a lipoxin-based drug for obese people to help protect them against associated illnesses, such as kidney and liver disease,

While the virus can lead to liver disease, it mostly runs its course with few long-term complications.

#Gel that can make drugs last longer A drug-delivering hydrogel has been developed to treat chronic diseases such as hepatitis C a liver disease that kills around 500,000 people worldwide every year.

Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have developed a drug-delivering hydrogel to treat chronic diseases such as hepatitis C a liver disease that kills around 500,000 people worldwide every year."

For example, the investigators teamed with Fabio Cominelli, MD, Phd, a Case Western Reserve Professor and Chief of the Division of Gastroenterology and Liver disease,

< Back - Next >

Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011